and history of infertility (22%) were more frequent if the applied during this study period were essentially similar (Serov et al., tumour occurred at fertile age (n ⍧ 50). Of the 12 infertile 1973), the GCT diagnosis being confirmed by a senior pathologist cases, seven had anovulatory infertility (58%); 11 occurred (T.W.) . Thecomas were excluded, but mixed granulosa-theca cell during the era of ovulation inducers, but only five had tumours with a clear granulosa cell component (n ϭ 14) were used these drugs (clomiphene citrate in five patients, gonadincluded. The data collection was incomplete in 42 cases and the otrophins in two, and tamoxifen in one patient) and no original diagnosis was not kept in 11 cases; thus the analysed series patient had undergone in-vitro fertilization. Endometrial and Obstetrics) criteria (AGOG, 1992) based on the data derived years. In conclusion, GCT at fertile age is associated with from primary surgery and histology.
nulliparity and with a clinical presentation of anovulatory
The patient files were scrutinized for relevant data on menstrual history, infertility, use of any hormones and for the signs of hyperinfertility, while GCT later in life is associated with a more oestrogenism (pre-or intra-operative urine or serum oestrogens, serum
Introduction
'infertile' (n ϭ 4). History of infertility could not be classified in 11 patients. If the patient had died, autopsy data were scrutinized in Ovarian granulosa cell tumours (GCT) arise from the sex-cord order to be certain that that the data were correct. stromal cells of the ovary and represent 2-3% of all ovarian
Women with GCT at a fertile age (from 16 to 45 years) were cancers (Young and Scully, 1987) . The reported incidence of identified and an analysis with reference to a possible use of ovulation GCT has varied from 0.58/100 000 to 1.6/100 000 (Stenwig inducers (available from 1966-67 in Finland) was performed. The et al ., 1979; Björkholm and Pettersson, 1980; Ohel et al., results were compared with two population-based databanks: (i) the 1983), and was reported as 0.62/100 000 in Finland (Unkilafertility data of a national fertility survey of 5105 Finnish women Kallio et al., 1998) . The cause of human GCT is unknown, aged 22 to 55 years in 1989 (Nikander, 1992 ; see their Table I :c, the although its inducibility in rodents by exogenous gonadotroprimary infertility rate of the survey was based on the answers of phins (Biskind et al., 1952; Tennent et al., 1990 ) and a possible 836 nulliparous women aged under 40 years, who were non-users of connection of GCT to infertility or infertility treatment or both contraceptives, to the question 'why do you not yet have children of your own?'); and (ii) a study on the incidence of infertility of 4730 (Willemsen et al., 1993; Rossing et al., 1994 ; Tarlatzis et al., (7) 11 (13) 14 (11) Adenomatous hyperplasia 1 (2) 10 (12) 11 (9) Cancer -(-) 10 (12) 10 (8) Normal 26 (63) 25 (29) 54 (42) *Percentages calculated from the data available. # Analysis of the same age group as the reference. Subgroups in the GCT series corresponding to the age group of the reference study: Pietinen et al., 1996 (n ϭ 86; age 30-59 years in our series); Nikander, 1992 (n ϭ 62; age 22-51 in our series); Nikander, 1992 (n ϭ 31; age Ͻ40 years in our series); Rantala, 1986 (n ϭ 26; age 30-40 years in our series). a Widholm and Kantero, 1971 (n ϭ8111 girls, 10-20 years old in 1969); b Pietinen et al., 1996 (n ϭ734, 30-59 of variance, when appropriate. A P-value of Ͻ 0.05 was considered significant.
Results
GCT was diagnosed at a potentially fertile age in 50 of the 146 women studied. Relevant clinical variables are given in Table I . The majority of the tumours (120/146, 82%) were found in women aged 35 to 75 years at the time of tumour diagnosis ( Figure 2A) ; the mean age at diagnosis of all cases was 53.0 (range 16 to 87) years; median age at menopause was 50.0 (range 36 to 59) years, which compared well with the population-based median age of 51.0 years (Topo and Hemminki, 1995) . Of the 50 cases, 41 occurred after the introduction of ovulation inducers, but only five women had used these drugs, all because of anovulatory infertility (Table II) . Altogether, 12 patients had complained of infertility, and in 11 of these the tumour was present at a fertile age. Cases 9 and 12 have been reported earlier in detail (Unkila-Kallio et al., 1997) . The Table I .
Statistical analysis included unpaired t-test, χ 2 analysis and analysis diagnosis. One underwent surgery because of an extra-uterine to have premature menopause (before the age of 40). Signs of hyperoestrogenism determined by elevated preoperative urine or serum oestrogens concentrations (high compared with references used at that time) were found in 14 postmenopausal of the 18 evaluated (78%). Papanicolau smear in postmenopausal women not using oestrogen therapy revealed an increased oestrogen index (Ͼ1) in 27 out of 53 samples (51%). Serum FSH concentrations were low (Ͻ40 IU/l) in three out of seven postmenopausal patients studied. Hyperplasia of the endometrium occurred at all ages, but was much more frequent if GCT was diagnosed after the age of 45 (Table I) . Cancer of the endometrium was detected only in women with GCT after fertile age (from 54 to 78 years) (P Ͻ 0.0001), and had been the indication for surgery in four cases. Hysterectomy prior to diagnosis of GCT was performed in 11 (8%) women, two of whom developed GCT at fertile age. Hysterectomy had been indicated because of fibroids in eight women, an ovarian tumour in one woman (thecoma), uterine malignancy in one, and a descended uterus in one. In addition, two women had undergone unilateral oophorectomy before diagnosis of a GCT at fertile age: one because of an ovarian dermoid cyst 7 years earlier, and the other because of an extra-uterine pregnancy 20 years earlier. Two women had repeatedly been operated on for endometriosis prior to subsequent GCT and one woman had concomitant ovarian endometriosis with GCT (in this case without a history of infertility). Breast cancer prior to GCT was diagnosed in four women, two of them at fertile age. The time elapsed between breast cancer and GCT varied from 4 to 10 years.
Thirteen women (13%) were past users of oral contraceptives (used from 3 months up to 10 years). Cyclic progestin had been prescribed for 16 premenopausal women (16%), but hormone replacement therapy was prescribed only for eight postmenopausal women (10%).
No significant changes from decade to decade were noted in the age, menopausal status or parity in women developing GCT. In particular, the number of cases occurring at fertile age remained similar over the decades [24% (12/50) in 1956- We describe a series of 146 patients with ovarian GCT among whom information of the major reproductive variables could be found in over 90% of the cases. The total frequency of nulliparous women (32%) in our series was comparable with pregnancy, which turned out to be an ovarian pregnancy with a GCT in the other ovary. The other two pregnant women had that found in other large GCT series (14% to 36%) (Fox et al., 1975; Pankratz et al., 1978; Stenwig et al., 1979;  Björkholm ovarian masses at first-trimester check-ups and underwent abortions, one because of an advanced stage of the disease and Pettersson, 1980; Ohel et al., 1983) . The high rate of primary infertility (31%) and low parity (1.4), together with a and the other because of concomitant epithelial cancer of the opposite ovary.
doubled rate of nulliparous patients with GCT at a fertile age compared with population-based data, may be interpreted as The most common signs of the tumour in women with a uterus was oligo-amenorrhoea (45%) if GCT was diagnosed evidence of diminished fertility. Parity in women with GCT diagnosed after 45 years was similar to that identified in the at fertile age, and dysfunctional bleeding (71%) if the tumour was diagnosed at an older age. In postmenopausal women population-based data. The rate of anovulatory infertility among infertile couples (n ϭ 84), GCT was diagnosed on average 13 Ϯ 9 (SD) years after menopause ( Figure 2C ). Four women (5%) were thought with GCT (58%, 7/12) was high compared with the commonly Tamoxifen. B ϭ biopsy of the contralateral ovary; C ϭ chemotherapy; CC ϭ clomiphene citrate; DD ϭ died from disease; HCG ϭ hyperplasia cystica glandularis; HMG ϭ human menopausal gonadotrophin; N ϭ normal histology; NDA ϭ no data available; NED ϭ no evidence of disease; R ϭ radiotherapy; RE ϭ recurrence; S ϭ radical surgery; S 3 ϭ radical surgery after 3 months because of in-situ cervical cancer; S 6 ϭ radical surgery after 6 months at second look because of advanced disease; SO ϭ unilateral salpingo-oophorectomy.
given rate of one-third of infertile couples without GCT The 8% rate of endometrial cancer and 30% rate of endometrial hyperplasia are in concordance with earlier studies and (Rantala, 1988) . It seems likely that the hormonal effect of a are explained by hyperoestrogenism. These findings indicate GCT disturbs the menstrual cycle, producing oligo-amenorthat an endometrial sample is always necessary with GCT. rhoea and anovulatory infertility, and this leads to the patient However, no woman under 45 years presented with endometrial using ovulation inducers. The five users in this series represent cancer. This is in concordance with a summary of 926 case 4.2% of all the cases diagnosed after introduction of these reports of GCT from the early 1950s with no endometrial drugs (i.e. 5/118), a value comparable with the frequency of cancer reported in women under 40 years of age (Diddle, ovarian stimulation of 4.1% in both controls and cases in the 1951). Breast cancer was diagnosed before GCT in 3% of large Danish study of ovarian cancer and fertility drugs women, all of whom had clear signs of hyperoestrogenism at (Mosgaard et al., 1997) . It is noteworthy that none of our diagnosis of GCT. A recent report of a growing endometrial cases had participated in an IVF programme, despite ready cyst and multiple fibroids complicated by GCT also highlights availability. The use of ovulation inducers in our patients the potential clinical difficulty in diagnosing GCT when other lasted from one to nine cycles, and the tumours presented gynaecological pathology is present (Kurioka et al., 1998) . mainly at or within a year from the start of medication (3/5;
In conclusion, the main reproductive associations and con- Table II) . Thus, a causative link between GCT and ovulation sequences of patients with GCT appear not to have changed inducers seems unlikely, but the possible stimulatory effect on during the past few decades. Nulliparity is more common than the growth of an existing tumour remains possible. The effect in the general population, significantly so in women diagnosed of GCT on fertility is further supported by the100% rate of with GCT at fertile age. A high rate of infertility, especially spontaneous pregnancies after tumour removal in the previanovulatory infertility, is associated with GCT occurring at ously infertile women with intact uterus. This improved fertility fertile age. However, the use of ovulation-inducing drugs was after surgery was also evident in a previous series (Willemsen not greater than expected in this series. These findings, together et al., 1993) . Reported ongoing pregnancy rates with GCT with the 100% rate of spontaneous pregnancies after tumour have been 1.4-1.7% of untreated cases (Evans et al., 1980;  removal, support the theory that the existing tumour, rather Ohel et al., 1983) , corresponding well to the 2% of our series.
than ovulation inducers, is the link between infertility and GCT. Age at menarche and menopause, and the mean body mass index, have not differed from population means in reported
